Category: Specific Treatments

Specific Treatments

5-ASA

Mesalamine

Steroids

Budesonide

Infliximab

Remicade

Adalimumab

Humira

Thiopurines

Imuran, 6-MP

Vedolizumab

Entyvio

Ustekinumab

Stelara

Tofacitinib

Xeljanz

Email Newsletter

Recent News

Link observed between deficits in geriatric assessments, disease activity, burden in IBD
June 21, 2021
Q&A: Posttraumatic stress symptoms afflict patients with IBD
June 18, 2021
Researchers see no change in disease activity in patients with IBD, COVID-19
June 16, 2021
Entyvio, Stelara plus immunomodulators not as effective for IBD
June 9, 2021
ABX464 safe, effective in treating patients with ulcerative colitis
June 7, 2021
Pediatric IBD patients have more VTEs than general pediatric populace
June 4, 2021
FDA approves Zeposia for moderate-to-severe ulcerative colitis
May 28, 2021
Young IBD patients fail to develop neutralizing antibodies for SARs-CoV-2
May 26, 2021
Processed food consumption, IBD diagnosis
May 24, 2021
Racial, sex disparity in influenza vaccination rates in IBD
May 23, 2021